$1.09 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 23 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 12.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VRRM | Sell | VERRA MOBILITY CORP | $124,518,000 | -5.4% | 8,101,369 | -3.4% | 11.39% | -19.8% |
HLIT | Sell | HARMONIC INC | $99,665,000 | +16.8% | 7,625,490 | -22.5% | 9.12% | -1.0% |
ARMK | Sell | ARAMARK | $56,863,000 | -16.5% | 1,822,522 | -18.0% | 5.20% | -29.2% |
PTON | Sell | PELOTON INTERACTIVE INC | $28,974,000 | -34.3% | 4,180,956 | -12.9% | 2.65% | -44.2% |
GMS | Sell | GMS INC | $21,929,000 | -12.2% | 548,086 | -2.4% | 2.01% | -25.6% |
FISV | Sell | FISERV INC | $16,402,000 | -56.6% | 175,296 | -58.7% | 1.50% | -63.2% |
SONO | Sell | SONOS INC | $689,000 | -98.7% | 49,589 | -98.4% | 0.06% | -98.9% |
MHK | Exit | MOHAWK INDS INC | $0 | – | -410,451 | -100.0% | -5.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
ISHARES TR | 28 | Q3 2023 | 10.9% |
MANNKIND CORP | 24 | Q3 2023 | 0.5% |
BAIDU INC | 21 | Q2 2018 | 8.6% |
ITRON INC | 21 | Q3 2020 | 12.1% |
RETROPHIN INC | 20 | Q3 2020 | 4.5% |
HARMONIC INC | 19 | Q3 2023 | 10.5% |
JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-04-26 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2024-01-22 |
13F-HR/A | 2023-11-14 |
13F-HR | 2023-11-14 |
SC 13D | 2023-09-21 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.